Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Caspase 8 small interfering RNA prevents acute liver failure in mice.

Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gosling T, Flemming P, Malek NP, Trautwein C, Manns MP, Kuhnel F, Kubicka S.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7797-802. Epub 2003 Jun 16.

2.

RNA interference targeting Fas protects mice from fulminant hepatitis.

Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J.

Nat Med. 2003 Mar;9(3):347-51. Epub 2003 Feb 10.

PMID:
12579197
3.

Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.

Contreras JL, Vilatoba M, Eckstein C, Bilbao G, Anthony Thompson J, Eckhoff DE.

Surgery. 2004 Aug;136(2):390-400.

PMID:
15300206
4.

Fas siRNA reduces apoptotic cell death of allogeneic-transplanted hepatocytes in mouse spleen.

Wang J, Li W, Min J, Ou Q, Chen J.

Transplant Proc. 2003 Jun;35(4):1594-5.

PMID:
12826229
6.

Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.

Matsuki Y, Li L, Hsu HC, Yang PA, Zheng R, Edwards CK 3rd, Chaudry IH, Zhang HG, Mountz JD.

Cell Death Differ. 2002 Jun;9(6):626-35.

7.

Novel role for amphiregulin in protection from liver injury.

Berasain C, García-Trevijano ER, Castillo J, Erroba E, Santamaría M, Lee DC, Prieto J, Avila MA.

J Biol Chem. 2005 May 13;280(19):19012-20. Epub 2005 Mar 7.

8.

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L.

J Exp Med. 1995 Nov 1;182(5):1223-30.

9.

Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock.

Matsuda N, Takano Y, Kageyama S, Hatakeyama N, Shakunaga K, Kitajima I, Yamazaki M, Hattori Y.

Cardiovasc Res. 2007 Oct 1;76(1):132-40. Epub 2007 Jun 5.

PMID:
17601517
10.

CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications.

Janin A, Deschaumes C, Daneshpouy M, Estaquier J, Micic-Polianski J, Rajagopalan-Levasseur P, Akarid K, Mounier N, Gluckman E, Socié G, Ameisen JC.

Blood. 2002 Apr 15;99(8):2940-7.

11.
12.

Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice.

Li XK, Fujino M, Guo L, Okuyama T, Funeshima N, Hashimoto M, Okabe K, Yaginuma H, Mikoshiba K, Enosawa S, Amemiya H, Suzuki S.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):101-9.

PMID:
10873571
13.

Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis.

Guillot C, Coathalem H, Chetritt J, David A, Lowenstein P, Gilbert E, Tesson L, van Rooijen N, Cuturi MC, Soulillou JP, Anegon I.

J Immunol. 2001 Apr 15;166(8):5225-35.

14.

The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis.

Park KT, Mitchell KA, Huang G, Elferink CJ.

Mol Pharmacol. 2005 Mar;67(3):612-22. Epub 2004 Nov 18.

15.

The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.

Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A, Buendia MA.

Oncogene. 2002 Jan 17;21(3):377-86.

16.

In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.

Woo M, Hakem A, Elia AJ, Hakem R, Duncan GS, Patterson BJ, Mak TW.

J Immunol. 1999 Nov 1;163(9):4909-16.

17.

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.

Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, Yasumi T, Watanabe K, Nishikomori R, Nakayama T, Yonehara S, Toguchida J, Nakahata T.

Oncogene. 2003 Dec 18;22(58):9231-42.

PMID:
14647441
18.

Efficient delivery of siRNA into cytokine-stimulated insulinoma cells silences Fas expression and inhibits Fas-mediated apoptosis.

Burkhardt BR, Lyle R, Qian K, Arnold AS, Cheng H, Atkinson MA, Zhang YC.

FEBS Lett. 2006 Jan 23;580(2):553-60. Epub 2005 Dec 29.

19.

Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis.

Matsuda N, Yamamoto S, Takano K, Kageyama S, Kurobe Y, Yoshihara Y, Takano Y, Hattori Y.

Am J Respir Crit Care Med. 2009 May 1;179(9):806-15. doi: 10.1164/rccm.200804-534OC. Epub 2009 Feb 6.

PMID:
19201926
20.

The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse.

Malassagne B, Ferret PJ, Hammoud R, Tulliez M, Bedda S, Trébéden H, Jaffray P, Calmus Y, Weill B, Batteux F.

Gastroenterology. 2001 Dec;121(6):1451-9.

PMID:
11729124

Supplemental Content

Support Center